XML 31 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2018
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
March 31,
2018
   
 
Range,
March 31,
2018
   
Weighted
Average,
March 31,
2017
   
 
Range,
March 31,
2017
 
Volatility
   
74
%    
68%
-
75
%    
79
%    
78%
-
86
%
Dividend yield
   
-
     
 
-
 
     
-
     
 
-
 
 
Risk-free interest rate
   
2.44
%    
1.75%
-
2.64
%    
1.14
%    
0.82%
-
1.17
%
Expected term (years)
   
5
     
3
-
6
     
4
     
3
-
4
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
   
 
 
 
 
Options
   
 
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
 
 
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2017
   
4,545,037
    $
1.42
     
2.9
    $
176,575
 
Granted
   
2,647,500
     
0.76
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
(365,312
)    
-
     
 
     
 
 
Outstanding at March 31, 2018
   
6,827,225
    $
1.11
     
4.0
    $
-
 
Exercisable at March 31, 2018
   
6,827,225
    $
1.11
     
4.0
    $
-
 
Schedule of Nonvested Share Activity [Table Text Block]
   
 
 
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2017
   
25,000
    $
0.46
 
Granted
   
2,647,500
     
0.52
 
Vested
   
(2,672,500
)    
0.51
 
Nonvested at March 31, 2018
   
-
    $
-
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three
months
ended
March 31,
2018
   
Three
months
ended
March 31,
2017
   
Nine months
ended
March 31,
2018
   
Nine months
ended
March 31,
2017
 
General and administrative:
                               
Fair value of stock/warrant bonuses expensed
  $
1,500
    $
-
    $
8,723
    $
6,830
 
Change in fair value from modification of option terms
   
-
     
-
     
243,761
     
166,031
 
Change in fair value from modification of warrant terms
   
7,091
     
-
     
163,956
     
-
 
Fair value of stock options expensed
   
682,485
     
6,134
     
782,135
     
112,699
 
Total
  $
691,076
    $
6,134
    $
1,198,575
    $
285,560
 
                                 
Research and development:
                               
Fair value of stock bonus expensed
  $
-
    $
-
    $
15,098
    $
7,954
 
Change in fair value from modification of option terms
   
-
     
-
     
105,895
     
11,440
 
Change in fair value from modification of warrant terms
   
219
     
-
     
132,896
     
-
 
Fair value of stock options expensed
   
587,215
     
-
     
587,215
     
23,251
 
Total
  $
587,434
    $
-
    $
841,104
    $
42,645